Advances in nano-delivery of natural products for cancer therapy: mechanisms and translational strategies
Biomedical Materials · 2026
DOI: 10.1088/1748-605x/ae7ee2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomedical Materials, 2026. Verfasst von Xiang Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Mudanjiang Medical University, Mudanjiang 157011, People's Republic of China. Hauptthemen laut MEDLINE: Biological Products, Neoplasms, Antineoplastic Agents, Nanoparticles. Die Arbeit nennt 160 Literaturangaben. Gefördert von: Long-gang District Medical and Health Technology Research Project, Research Project of the Fundamental Research Funds for Provincial Universities of Heilongjiang Province, Shenzhen Science and Technology Program.
Abstract (Originalsprache)
Cancer remains a major global health burden, with conventional monotherapies often limited by recurrence, therapeutic resistance, and systemic toxicity. Natural products, derived from diverse sources and characterized by distinct chemical structures, exhibit broad anticancer potential by modulating multiple molecular pathways. However, their clinical application is frequently constrained by poor solubility, low bioavailability, and chemical instability. Nano-delivery systems (NDS) have emerged as a promising strategy to address these limitations by improving pharmacokinetic properties, stabilizing labile compounds, and enabling co-delivery with conventional therapeutics, thereby supporting multimodal and synergistic interventions. This review provides a comprehensive overview of natural product-based NDS in cancer therapy, beginning with classification strategies and mechanistic frameworks, followed by an analysis of how NDS enhance pharmacological performance and facilitate integration into combination regimens. Finally, it highlights key translational challenges and opportunities, offering a foundation for the future development and clinical translation of natural product-based NDS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mudanjiang Medical University, Mudanjiang 157011, People's Republic of China.
- Shenzhen Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen 518116, People's Republic of China.
- Longgang Central Hospital, Shenzhen 518116, People's Republic of China.
ORCID-Profile: Jianbo Yu
Förderung
- Long-gang District Medical and Health Technology Research Project
- Research Project of the Fundamental Research Funds for Provincial Universities of Heilongjiang Province
- Shenzhen Science and Technology Program
- Institutional Research Talent Development Fund of Longgang Central Hospital
Zitieren
APA
Chen, X., Wu, H., Pan, X., Li, W., Dai, H., Wang, H., Mao, J., & Yu, J. (2026). Advances in nano-delivery of natural products for cancer therapy: mechanisms and translational strategies. Biomedical Materials. https://doi.org/10.1088/1748-605x/ae7ee2
Vancouver
Chen X, Wu H, Pan X, Li W, Dai H, Wang H, et al. Advances in nano-delivery of natural products for cancer therapy: mechanisms and translational strategies. Biomedical Materials. 2026. doi:10.1088/1748-605x/ae7ee2
BibTeX
@article{Chen2026,
author = {Chen, Xiang and Wu, Huibin and Pan, Xinyu and Li, Weiqun and Dai, Haibing and Wang, Han and Mao, Jie and Yu, Jianbo},
title = {Advances in nano-delivery of natural products for cancer therapy: mechanisms and translational strategies},
journal = {Biomedical Materials},
year = {2026},
doi = {10.1088/1748-605x/ae7ee2}
}
EUVIMED